Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Armata Pharmaceuticals (ARMP) EPS (Basic) (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed EPS (Basic) for 6 consecutive years, with -$0.24 as the latest value for Q4 2018.

  • Quarterly EPS (Basic) fell 500.0% to -$0.24 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was -$1.76 through Dec 2018, up 46.34% year-over-year, with the annual reading at -$4.8 for FY2025, 823.08% down from the prior year.
  • EPS (Basic) hit -$0.24 in Q4 2018 for Armata Pharmaceuticals, up from -$0.6 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $3.87 in Q3 2014 to a low of -$8.22 in Q1 2016.
  • Historically, EPS (Basic) has averaged -$1.23 across 5 years, with a median of -$0.57 in 2018.
  • Biggest YoY gain for EPS (Basic) was 1700.0% in 2014; the steepest drop was 10500.0% in 2014.
  • Year by year, EPS (Basic) stood at -$0.25 in 2014, then plummeted by 116.0% to -$0.54 in 2015, then fell by 29.63% to -$0.7 in 2016, then skyrocketed by 94.29% to -$0.04 in 2017, then crashed by 500.0% to -$0.24 in 2018.
  • Business Quant data shows EPS (Basic) for ARMP at -$0.24 in Q4 2018, -$0.6 in Q3 2018, and -$0.68 in Q2 2018.